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	 Vanadium	 complexes	 containing	 Schiff	 base	 ligands	 are	 of	 great	 importance	 and	 have
numerous	applications.	A	series	of	Schiff	base	ligands	derived	from	4‐amino‐5‐mercapto‐3‐
phenyl‐1,2,4‐triazole	 and	 different	 aldehydes	 were	 synthesized	 and	 combined	 with
ammonium	metavanadate	in	2:1	and	1:1	molar	ration	to	yield	oxo‐	and	dioxo‐vanadium(V)
complexes	NH4[VO(La‐f)2]	and	NH4[VO2(Lg‐h)2],	respectively.	The	structure	of	the	synthesized
compounds	was	confirmed	by	elemental	analysis,	UV,	IR,	NMR,	MS	and	TGA.	Complexes	with
bidentate	 and	 tridentate	 ligands	 were	 expected	 to	 possess	 a	 distorted	 square‐pyramidal
structure.	 The	 ligands	 and	 their	 complexes	 have	 been	 examined	 for	 antimicrobial	 activity
against	six	types	of	bacteria	and	one	kind	of	fungus	that	widely	distributed	in	Albaha	region,
Kingdom	of	Saudi	Arabia.	The	results	indicate	that	some	of	the	complexes	were	active	against
C.	albicans	fungus	when	used	as	powder,	and	no	sound	activity	were	shown	against	any	type
of	tested	bacteria.	
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1.	Introduction	
	
Vanadium	 complexes	 have	 received	 intensive	 studies	 in	
many	research	laboratories	in	the	recent	decades	due	to	their	
role	 in	 bio‐coordination	 chemistry	 and	 they	 represent	
functional	 and	 structural	 models	 for	 biological	 systems	 [1].	
Vanadium	complexes	containing	pharmacologically	interesting	
moieties	 have	 considerable	 interest	 in	 drug	 discovery.	 They	
have	been	 reported	 to	 exhibit	 excellent	 role	 in	 the	 biological	
and	 pharmacological	 research	 studies	 in	 vivo	 and	 in	 vitro	
systems	 as	 antimicrobial,	 anti‐carcinogenic	 and	 antileish‐
manial	agents	[2‐6].	They	show	important	role	as	enhancers	of	
oxygen	 affinity	 by	 hemoglobin	 and	myoglobin	 and	 they	 have	
insulin‐mimetic	activity	[7‐9].	
Dioxodovanadium(V)	 complexes	 in	 particular	 have	 been	
reported	to	interact	with	biologically	active	organic	molecules	
which	 allow	 them	 of	 a	 competent	 study	 of	 their	 action	 in	
biochemical	 processes	 [1].	 VO2(4‐n‐butyl‐semicarbazone)	
complex	 reported	 to	 exhibit	 insulin‐mimetic	 activity	 in	 the	
presence	 of	 ascorbic	 acid	 [9].	 Also,	 vanadium	 dipicolinate	
complex	NH4[VO2(dipic)]	was	reported	 to	be	very	effective	 in	
lowering	blood	glucose	in	animal	studies	and	the	effectiveness	
was	dependent	on	the	ligand	and	the	vanadium	oxidation	state	
[10].	Oxovanadium(V)	complexes	reported	to	have	potent	dual	
anti‐HIV	 and	 spermicidal	 activities	 [11].	 In	 addition,	 Schiff	
bases	 and	 their	metal	 complexes	 played	 a	 prominent	 role	 in	
the	development	of	coordination	chemistry.	They	represent	an	
attractive	 field	 of	 research	 due	 to	 their	 structural	 features,	
special	activities	 in	pharmacology,	biological	 systems	and	 the	
wide	range	of	applications	[12,13].		
Compounds	 incorporating	 the	 3‐substituted‐4‐amino‐5‐
mercapto‐1,2,4‐triazoles	substructure	exhibit	a	wide	spectrum	
of	 biological	 activity	 and	 contain	 an	 amino	 and	 mercapto	
groups	which	has	the	ability	to	coordinate	metal	ions	[14].		
The	 interaction	 of	 vanadium	 species	 with	 Schiff	 base	
ligands	bearing	therapeutic	applications	is	of	growing	focus	of	
attention	and	driven	a	considerable	amount	of	 research	 [15].	
Various	vanadium	complexes	with	Schiff	base	ligands	contain‐
ing	 1,2,4‐triazole	 moiety	 are	 used	 in	 pharmacological	 and	
biological	research	studies	found	to	exhibit	important	roles	in	
biological	 applications	 [16].	 It	 has	 been	 reported	 that	 many	
compounds	 containing	 1,2,4‐traizole	 moiety	 are	 having	
insecticidal,	fungicidal	and	herbicidal	activity	[17].		
In	 view	 of	 the	 facts	 mentioned	 before,	 we	 considered	
interesting	 to	 design	 new	 compounds	 in	 a	 trial	 to	 develop	 a	
molecule	 combining	 different	 pharmacophore	 fragments	 in	
one	structure,	which	may	lead	to	interesting	biologically	active	
agents.		
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Scheme	1
	
	
We	 have	 synthesized	 a	new	oxo‐	 and	 dioxovanadium	 (V)	
complexes	from	a	series	of	bidentate	and	tridentate	Schiff	base	
ligands	 derived	 from	 4‐amino‐5‐mercapto‐3‐phenyl‐1,2,4‐
triazole	 condensed	 with	 different	 aldehydes.	 The	 newly	
synthesized	 vanadium	 complexes	 were	 characterized	 by	
elemental	 analysis,	 spectroscopic	 and	 physicochemical	
methods.	 The	 microbial	 activities	 of	 the	 ligands	 and	 their	
corresponding	 complexes	were	 tested	 against	 six	 pathogenic	
bacteria	 (Staphylococcus	 aureus,	 Enterococcus	 faecalis,	 and	
Group	 B	 streptococcus	 (GBS))	 as	 Gram‐positive	 bacteria,	 and	
(Proteus	mirabilis,	 Escherichia	 coli,	 Klebsiella	 pneumoniae)	 as	
Gram‐negative	 bacteria,	 in	 addition	 to	 one	 kind	 of	 fungi	
(Candida	 albicans)	 to	 assess	 their	 antimicrobial	 properties.	
These	 microbes	 are	 widely	 distributed	 at	 Albaha	 region,	
Kingdom	of	Saudi	Arabia.		
	
2.	Experimental	
	
2.1.	Chemicals	
	
All	 chemicals	 used	 in	 this	 work	 NH4VO3,	 benzaldehyde,	
salicylaldehyde,	 o‐vaniline,	 anisaldehyde,	 vaniline,	 p‐hydroxy	
benzaldehyde,	 2‐chlorobenzaldehyde,	 4‐chlorobenzaldehyde	
were	 purchased	 from	 Sigma‐Aldrich	 and	 used	 as	 received	
without	purification.	The	4‐amino‐5‐mercapto‐3‐phenyl‐1,2,4‐
triazole	 has	 been	 synthesized	 according	 to	 the	 reported	
methods	[18].	
	
2.2.	Preparation	of	Schiff	base	ligands	
	
Schiff	base	ligands	(La‐Lh)	were	prepared	from	the	conden‐
sation	of	the	amino	compound	4‐amino‐5‐mercapto‐3‐phenyl‐
1,2,4‐triazole	 and	 an	 aldehyde	 compound:	 benzaldehyde,	
salicylaldehyde,	o‐vaniline,	 anisaldehyde,	 vaniline,	p‐hydroxy‐
benzaldehyde,	 2‐chlorobenzaldehyde,	 p‐chlorobenzaldehyde	
(1:1)	 molar	 ratio	 in	 an	 ethanolic	 solution	 and	 refluxing	 for	
nearly	3	hours	 in	 the	presence	of	piperidine	according	 to	 the	
reported	 method	 [19,20].	 The	 solvent	 was	 evaporated	
partially	 and	 the	 yellow/orange	 precipitates	 were	 collected	
and	 dried	 under	 vacuum.	 Yield	 ranges	 between	 70‐85%	
(Scheme	1).	
4‐(Benzylideneamino)‐5‐phenyl‐4H‐1,	 2,	 4‐triazole‐3‐thiol	
(La):	Color:	Yellow.	Yield:	70%.	M.p.:	190‐192	°C.	FT‐IR	(KBr,	,	
cm‐1):	 1600	 (C=N),	 2743	 (SH).	 Anal.	 calcd.	 for	 C15H12N4S:	 C,	
64.26;	H,	4.31;	N,	19.99;	S,	11.44.	Found:	C,	64.36;	H,	4.28;	N,	
19.92;	S,	11.26%.		
4‐((4‐Methoxybenzylidene)amino)‐5‐phenyl‐4H‐1,	2,	4‐tria	
zole‐3‐thiol	 (Lb):	 Color:	 Brownish	 yellow.	 Yield:	 85%.	 M.p.:	
185‐187	°C.	FT‐IR	(KBr,	,	cm‐1):	1613	(C=N),	2642	(SH).	Anal.	
calcd.	 for	 C16H14N4SO:	 C,	 61.92;	 H,	 4.55;	 N,	 18.05;	 S,	 10.33.	
Found:	C,	61.88;	H,	4.49;	N,	17.96;	S,	10.27%.		
4‐(((3‐Mercapto‐5‐phenyl‐4H‐1,	 2,	 4‐triazol‐4‐yl)imino)	
methyl)phenol	 (Lc):	 Color:	 Yellow.	 Yield:	 75%.	 M.p.:	 175‐177	
°C.	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1602	 (C=N),	 2750	 (SH),	 3295	 (OH).	
Anal.	calcd.	for	C15H12N4SO:	C,	60.80;	H,	4.08;	N,	18.91;	S,	10.82.	
Found:	C,	60.62;	H,	4.02;	N,	18.86;	S,	10.77%.		
4‐((4‐Chlorobenzylidene)amino)‐5‐phenyl‐4H‐1,2,4‐triazole‐
3‐thiol	(Ld):	Color:	Yellow.	Yield:	80%.	M.p.:	192‐194	°C.	FT‐IR	
(KBr,	 ,	 cm‐1):	 1606	 (C=N),	 2756	 (SH).	 Anal.	 calcd.	 for	
C15H11N4SCl:	 C,	 57.23;	 H,	 3.52;	 N,	 17.80;	 S,	 10.18.	 Found:	 C,	
57.14;	H,	3.49;	N,	17.82;	S,	10.10%.		
4‐((2‐Chlorobenzylidene)amino)‐5‐phenyl‐4H‐1,2,4‐triazole‐
3‐thiol	(Le):	Color:	Brownish	yellow.	Yield:	80%.	M.p.:	180‐182	
°C.	FT‐IR	(KBr,	,	cm‐1):	1620	(C=N),	2757	(SH).	Anal.	calcd.	for	
C15H11N4SCl:	 C,	 57.23;	 H,	 3.52;	 N,	 17.80;	 S,	 10.18.	 Found:	 C,	
57.20;	H,	3.49;	N,	17.70;	S,	10.12%.		
4‐(((3‐Mercapto‐5‐phenyl‐4H‐1,	 2,	 4‐triazol‐4‐yl)imino)	
methyl)‐3‐methoxyphenol	(Lf):	Color:	Yellow.	Yield:	70%.	M.p.:	
182‐184	°C.	FT‐IR	(KBr,	,	cm‐1):	1605	(C=N),	2810	(SH),	3265	
(OH).	Anal.	calcd.	for	C16H14N4SO2:	C,	58.88;	H,	4.32;	N,	17.17;	S,	
9.82.	Found:	C,	58.92;	H,	4.20;	N,	17.10;	S,	9.76%.	
2‐(((3‐Mercapto‐5‐phenyl‐4H‐1,	 2,	 4‐triazol‐4‐yl)imino)	
methyl)	phenol	(Lg):	Color:	Brownish	yellow.	Yield:	70%.	M.p.:	
151‐153	°C.	FT‐IR	(KBr,	,	cm‐1):	1616	(C=N),	2759	(SH),	3289	
(OH).	Anal.	calcd.	for	C15H12N4SO:	C,	60.80;	H,	4.08;	N,	18.91;	S,	
10.82.	Found:	C,	60.75;	H,	4.10;	N,	18.87;	S,	10.80%.		
2‐(((3‐Mercapto‐5‐phenyl‐4H‐1,	 2,	 4‐triazol‐4‐yl)imino)	
methyl)‐6‐methoxyphenol	 (Lh):	Color:	Pale	brown.	Yield:	85%.	
M.p.:	206‐208	°C.	FT‐IR	(KBr,	,	cm‐1):	1643	(C=N),	2750	(SH),	
3295	 (OH).	 Anal.	 calcd.	 for	 C16H14N4SO2:	 C,	 58.88;	H,	 4.32;	N,	
17.17;	S,	9.82.	Found:	C,	58.82;	H,	4.30;	N,	16.98;	S,	9.80%.		
	
2.3.	Preparation	of	metal	complexes		
	
To	a	hot	magnetically	stirred	(50	mL)	ethanolic	solution	of	
the	triazole	Schiff	base	(2	mmol),	a	solution	of	NH4VO3	(0.117g,	
1	mmol)	 in	 30	ml	 hot	water	was	 added	 slowly	with	 stirring.	
The	mixture	was	stirred	and	heated	directly	on	a	wire	gauze	
for	one	hour	during	which	a	precipitated	product	was	formed.	
The	 precipitates	 thus	 formed	 were	 filtered,	 washed	 with	
methanol,	dioxane	and	then	with	diethyl	ether	and	dried	under	
vacuum.	The	yields	obtained	were	in	the	range	of	65‐70%.	All	
complexes	were	prepared	following	the	same	procedure	using	
2:1	 and	 1:1	 (L:M)	 molar	 ratio	 in	 case	 of	 bidentate	 and	
tridentate	Schiff	bases,	respectively.	
		
2.4.	Instrumentation	
	
Elemental	 analyses	 (C,	 H,	 N,	 O	 and	 S)	 were	 performed	
using	Leco	VTF‐900	CHN‐S‐O	932	version	1.3x	(ThermoFisher	
Scientific‐USA)	 instrument.	 Electronic	 spectra	 of	 solutions	 of	
the	complexes	in	DMF	were	recorded	on	Evolution	300	UV‐vis	
Spectrophotometer.	 FT‐IR	 spectra	 (400‐4000	 cm‐1)	 were	
recorded	as	KBr	discs	using	Nicolet	 IS50	FT‐IR	spectrophoto‐
meter.	The	mass	 spectra	were	 carried	out	on	LC‐MS	 spectro‐
meter	 of	 Thermo	 Scientific	 3000	 series.	 Thermogravimetric	
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analysis	 (TGA)	 was	 recorded	 on	 Shimadzu	 analyzer	 50	 in	 a	
dynamic	nitrogen	atmosphere	(100	mL/min)	at	a	heating	rate	
10	 °C/min.	 Circular	 NMR	 spectra	 were	 obtained	 in	 CD3OD	
solutions	 with	 a	 Varian	 Mercury‐400BB	 (400	 MHz)	 spectro‐
meter	using	TMS	(1H)	as	standard.	
	
2.5.	Antimicrobial	activity	
	
The	 microbial	 activities	 of	 the	 ligands	 and	 their	
corresponding	 complexes	were	 tested	 against	 six	 pathogenic	
bacteria	 (Staphylococcus	 aureus,	 Enterococcus	 faecalis,	 and	
Group	 B	 streptococcus	 (GBS))	 as	 Gram‐positive	 bacteria,	 and	
(Proteus	mirabilis,	 Escherichia	 coli,	 Klebsiella	 pneumoniae)	 as	
Gram‐negative	 bacteria,	 in	 addition	 to	 one	 kind	 of	 fungi	
(Candida	 albicans)	 to	 assess	 their	 antimicrobial	 properties.	
These	 microbes	 are	 widely	 distributed	 at	 Albaha	 region,	
Kingdom	of	Saudi	Arabia.		
The	 antibacterial	 and	 antifungal	 activities	 of	 the	 ligands	
and	 their	corresponding	vanadium	complexes	were	 tested	by	
Well	 Diffusion	 Assay	 method	 as	 the	 susceptibility	 testing	
method	 [21,22].	 The	 antibacterial	 and	 antifungal	 activities	
were	tested	for	their	in	vitro	growth	inhibitory	activity	against	
the	 investigated	 pathogenic	 bacterial	 and	 fungal	 strains	
cultured	 on	 the	 surface	 of	 a	 sterile	 Muller‐Hinton	 agar	 as	 a	
microbiological	 growth	 medium.	 The	 stock	 solution	 of	 the	
compounds	 was	 prepared	 by	 dissolving	 0.02	 g	 of	 each	
compound	in	5	mL	DMSO	as	solvent.	The	solvent	(DMSO)	was	
used	as	a	control	in	a	similar	manner	to	the	prepared	solutions	
of	 the	 tested	 compounds.	 Using	 sterile	 cork	 borer	 (6	 mm)	 a	
small	 hole	 in	 the	 middle	 of	 each	 dish	 was	 made.	 Then,	
solutions	 of	 the	 ligands	 and	 the	 corresponding	 complexes	 in	
DMSO	were	poured	into	the	holes	made	in	the	cultured	Muller‐
Hinton	agar	medium	and	incubated	for	a	period	of	24	hours	at	
37	°C.	After	the	incubation	period,	the	microbial	susceptibility	
was	monitored	 by	measuring	 the	 zones	 (in	 cm)	 around	 each	
hole	 at	 which	 the	 visible	 growth	 was	 completely	 inhibited.	
Each	sample	was	repeated	in	triplicate,	and	statistical	analyses	
were	 performed	 with	 SPSS	 16.0	 for	 windows.	 For	 statistical	
analysis	p	<	0.05	were	considered	statistically	significant.	Data	
were	presented	as	mean	±	standard	deviation	(SD).	
Also,	 we	 have	 performed	 the	 antifungal	 susceptibility	
against	Candida	albicans	of	the	organic	Schiff	base	ligands	and	
their	 corresponding	 dioxidovanadium	 complexes	 using	 the	
solid	 form	 of	 the	 compounds	 by	 spreading	 the	 solid	 powder	
(0.02	g)	on	the	surface	of	the	agar	medium.		
	
3.	Results	and	discussion	
	
3.1.	Synthesis,	elemental	analysis	and	structural	
description	
	
Our	 task	 was	 constructing	 vanadium(V)	 complexes	
containing	 Schiff	 base	 ligands	 with	 1,2,4‐triazole	 moiety	
having	mercapto	(‐SH)	group.	We	have	selected	these	 ligands	
for	our	investigation	because	such	ligands	have	N,	S	and/or	O	
as	 donor	 atoms	 and	 are	 expected	 to	 have/or	 enhance	
antimicrobial	 activity.	 The	 synthesis	 of	 the	 designed	 Schiff	
base	 ligands	were	 successfully	 achieved	 by	 the	 condensation	
of	 the	 amino	 compound	 4‐amino‐5‐mercapto‐3‐phenyl‐1,2,4‐
triazole	 with	 different	 aldehydes:	 salicylaldehyde,	 o‐vaniline,	
anisaldehyde,	 benzaldehyde,	 vaniline,	 p‐hydroxybenz‐	
aldehyde,	2‐chlorobenzaldehyde,	p‐chlorobenzaldehyde	in	the	
1:1	 molar	 ratio	 in	 an	 ethanolic	 solution	 and	 refluxing	 for	
nearly	 2	 hours	 [19,20].	 Scheme	 1	 illustrates	 our	 attempt	 to	
design	suitable	starting	materials	to	be	used	as	ligands	(La‐Lh).	
The	melting	points	and	colours	of	the	isolated	organic	ligands	
are	shown	in	Section	2.2.	
The	structures	of	the	isolated	Schiff	bases	were	supported	
by	 elemental	 analysis	 and	 spectroscopic	 measurements.	 The	
oxovanadium(V)	 Schiff	 base	 complexes	were	 obtained	by	 the	
reaction	 of	 the	 bidentate	 Schiff	 base	 ligands	 in	 ethanolic	
solution	 and	 ammonium	 metavanadate	 (NH4VO3)	 salt	 in	 hot	
water	 solution	 using	 1:1	 [L:M]	 molar	 ratio.	 While,	 the	
dioxovanadium(V)	Schiff	base	complexes	were	obtained	by	the	
reaction	 of	 the	 tridentate	 ligands	 and	 NH4VO3	 salt	 using	 1:1	
[L:M]	 molar	 ratio.	 The	 coloured	 air	 stable	 mononuclear	
vanadium	 complexes	were	 isolated.	 The	 proposed	 structures	
(1	and	2)	are	shown	in	Scheme	2.		
	
 
 
 
Structure	1	
	
	
	
	Structure	2	
Scheme	2	
	
General	 structures	 1	 and	2	give	 the	 perspective	 view	 of	
expected	 vanadium(V)	 complexes	 with	 the	 bidentate	 and	
tridentate	 Schiff	 base	 ligands,	 respectively	 (Scheme	 2).	
Structure	1	represent	complexes	with	bidentate	ligands	(La‐Lf)	
having	imino	N	(azomethine	nitrogen)	and	mercapto	S	(of	the	‐
SH)	 atoms	 as	 donor	 sites.	 The	 elemental	 analysis	 measure‐
ments	 revealed	 that	 one	NH4+	molecules	 are	 associated	with	
the	 complex	 for	 each	 monomeric	 unit	 in	 all	 complexes	
obtained.	 The	 elemental	 analysis	 results	 (Table	 1)	 also	
revealed	 that	 two	 complexes	 NH4[VO(La)2].2H2O	 and	
NH4[VO(Ld)2].2H2O	 were	 having	 two	 crystal	 H2O	 molecules	
associated	 with	 each	 unit	 of	 these	 complexes	 (Structure	 1b,	
Scheme	2).	The	V	atoms	in	the	bidentate	ligand	complexes	are	
in	 square‐pyramidal	 coordination	 environment	with	 one	 oxo	
(O)	atom	present	at	the	vanadium	center.		
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Table	1.	Elemental	analysis	result	of	the	synthesized	vanadium	complexes.		
Formula	 Mol.	Wt.	 Calcd.	(Found)	%	
C H N S	
NH4[VO(La)2].2H2O		
C30H30N9O3S2V					
679.68	 53.01	(53.12)	 4.44	(3.96)	 18.54	(18.30)	 9.43	(9.51)	
NH4[VO(Lb)2]																																			
C32H30N9O3S2V	
703.71	 54.61	(54.72) 4.29	(4.60) 17.91	(17.85)	 9.11	(8.80)
NH4[VO(Lc)2]	
C30H26N9O3S2V	
675.65	 53.32	(52.90) 3.87	(3.55) 18.65	(18.56)	 9.49	(9.20)
NH4[VO(Ld)2].2H2O	
C30H28N9O3S2VCl2	
748.57	 48.13	(48.61) 3.77	(4.10) 16.84	(16.58)	 8.56	(8.74)
NH4[VO(Le)2]	
C30H24N9OS2VCl2	
712.54	 50.56	(50.15)	 3.39	(3.80)	 17.69	(17.92)	 9.00	(8.60)	
NH4[VO(Lf)2]	
C32H30N9O5S2V	
735.09	 52.24	(51.96)	 4.11	(4.48)	 17.13	(16.95)	 8.71	(8.94)	
NH4[VO2(Lg)]	
C15H14N5O3SV	
395.30	 45.57	(45.85)	 3.57	(3.65)	 17.71	(17.94)	 8.11	(7.85)	
NH4[VO2(Lh)]	
C16H16N5O4SV	
425.33	 45.18	(45.24) 3.79	(3.96) 16.46	(16.72)	 7.53	(7.41)
	
	
	
	
Figure	1.	IR	spectrum	for	NH4[VO(Lb)2]	complex.
	
	
In	structure	2,	 the	vanadium	atom	is	 in	square‐pyramidal	
coordination	 with	 the	 tridentate	 ligands	 (Lg‐Lh)	 through	 its	
azomethine	 nitrogen,	 mercapto	 S	 atom	 and	 deprotonated	
phenolic	 oxygen	 atom	 (Scheme	 2).	 The	 coordination	 sphere	
completed	by	two	oxo	ligands	at	cis‐position	[9].		
Elemental	analyses	of	the	complexes	obtained	are	in	good	
agreement	 with	 the	 chemical	 formulae	 proposed	 for	 the	
compounds	(Table	1).	
The	 mass	 spectra	 were	 performed	 for	 some	 of	 the	
obtained	 complexes	 to	 determine	 the	 molecular	 weights.	 A	
molecular	peak	for	the	complex	NH4[VO(Lb)2]	was	observed	at	
702.08	 m/z	 which	 is	 equivalent	 to	 its	 calculated	 molecular	
weight	 (703.71	m/z).	 For	 the	 complex	 NH4[VO2(Lg)]	 a	 peak	
was	observed	at	396.04	m/z	confirming	the	formula	weight	for	
this	 complex	 (calculated	 395.317	 m/z).	 This	 confirms	 the	
formula	proposed	for	these	complexes.		
	
3.2.	Spectroscopic	characterization	of	the	ligands	and	
complexes	
	
3.2.1.	Infrared	spectra	
	
The	 IR	 spectra	 of	 Schiff	 base	 ligands	 and	metal	 complex	
compounds	were	 recorded	 and	a	 representative	 IR	 spectrum	
is	shown	in	Figure	1.	The	infrared	spectra	of	the	ligands	(La‐Lh)	
exhibit	bands	characteristic	of	 the	stretching	vibrations	of	SH	
(2642‐2800	 cm–1)	 and	 C=N	 (1600‐1666	 cm–1)	 (Table	 2)	
[23,24].	
The	 significant	 bands	 observed	 in	 the	 IR	 spectra	 of	 the	
complexes	 are	 given	 in	 Table	 2	 and	 the	 main	 points	 are	
discussed	below:		
i) Free	 ligands	 characteristic	 band	 of	 the	 thiol	 group	
ν(SH)	at	2642‐2800	cm–1	for	these	bands	are	absent	in	
the	 metal	 complexes	 indicating	 deprotonation	 of	 the	
thiol	 group	 and	 complexation	 of	 sulfur	 atom	 with	
metal	 ions.	A	new	 low	frequency	band	appears	 in	 the	
metal	chelates	in	the	region	436‐499	cm‐1	(assigned	to	
ν(V‐S))	 confirms	 the	vanadium‐sulfur	bond	 formation	
[25,26].	
ii) The	 strong	 sharp	 bands	 appeared	 in	 the	 range	1600‐
1666	cm–1	are	assigned	to	azomethine	group	ν(C=N)	of	
the	 free	 ligand.	 These	 bands	 were	 shifted	 to	 lower	
frequency	 and	 reduced	 intensity	 on	 complex	 forma‐
tion,	 suggesting	 the	 participation	 of	 nitrogen	 atom	 of	
azomethine	group	in	coordination	[20].	This	is	further	
supported	 by	 the	 presence	 of	 a	 new	 low	 frequency	
band	 in	 the	 region	 491‐531	 cm‐1	 in	 the	 IR	 spectra	 of	
the	vanadium	complexes	assigned	to	ν(V‐N)	[25,26].		
iii) The	spectra	of	 the	bidentate	complexes	show	a	 sharp	
strong	band	in	the	range	949‐979	cm‐1	indicative	of	the	
presence	of	ν(V=O)	stretch	[27].	
iv) Two	 strong	 bands	 identified	 in	 the	 vanadium	
complexes	with	tridentate	ligands	spectra	in	the	range	
949‐968	 and	 968‐979	 cm‐1	 can	 be	 assigned	 to	
symmetrical	 ν(O=V=O)	 and	 asymmetrical	 ν(O=V=O)	
stretching	 vibrations,	 respectively	 [28].	 This	 clearly	
indicates	 the	dioxo	nature	of	 these	complexes	 [24,29‐
31].	The	frequencies	for	O=V=O	bonds	in	all	tridentate	
complexes	were	nearly	 similar	which	 is	 an	 indication	
that	all	 tridentate	complexes	have	VO2+	groups.	These	
are	 well	 within	 the	 range	 expected	 for	 dioxo‐
vanadium(V)	 compounds	 and	 in	 agreement	 with	 the	
other	results	[27].	
v) The	 IR	 spectrum	 of	 tridentate	 ligands	 (Lg‐Lh)	 exhibit	
ν(C‐O)	(phenolic)	stretches	at	1645	and	1580	cm‐1.	On	
coordination,	 these	bands	shifted	 to	higher	energy	by	
~25	cm‐1	that	indicates	coordination	through	phenolic	
oxygen	[19].		
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Table	2.	Characteristic	IR	bands	of	the	Ligands	(La‐Lh)	and	their	vanadium	complexes.	
Compound	 C=N	 OH	 SH	 VO/VO2	 V‐N	 V‐S	
La	 1600	 ‐ 2743 ‐ ‐	 ‐
NH4[VO(La)2].2H2O	 1622	 3514 2750 975 499	 450
Lb	 1613,	1666	 ‐	 2642	 ‐	 ‐	 ‐	
NH4[VO(Lb)2]	 1614,	1667	 ‐	 2791	 950	 531	 499	
Lc	 1602	 3295	 2750	 ‐	 ‐	 ‐	
NH4[VO(Lc)2]	 1567	 3300	 2800	 979	 520	 491	
Ld	 1606	 ‐ 2756 ‐ ‐	 ‐
NH4[VO(Ld)2].2H2O	 1650,	1592	 3400 2806 972 491	 436
Le	 1620	 ‐ 2757 ‐ ‐	 ‐
NH4[VO(Le)2]	 1616	 ‐ 2805 972,	957 506	 490
Lf	 1605	 3272 2800 ‐ ‐	 ‐
NH4[VO(Lf)2]	 1606	 3265 2810 958,	977 506	 470
Lg	 1616	 3289 2759 ‐ ‐	 ‐
NH4[VO2(Lg)2]	 1617	 ‐	 2801	 973	 500	 450	
Lh	 1600,	1643	 3295	 2750	 ‐	 ‐	 ‐	
NH4[VO2(Lh)2]	 1598,	1688	 ‐ 2748 949,	968 527	 473
	
	
	
Figure	2.	The	electronic	spectrum	of	NH4[VO2(Lh)2].
	
	
vi) A	band	centered	in	the	range	of	3110‐3155	cm‐1	is	due	
to	 ammonium	 stretching	 mode	 while	 cation	 NH4+	
deformation	 modes	 appear	 at	 1615	 and	 1430	 cm‐1	
[32,33].		
vii) 	In	 the	 IR	 spectra	 of	 some	 complexes	 a	 broad	 band	
appear	 at	 3400‐3514	 cm‐1	 due	 to	 ν(OH)	 which	 is	 an	
evident	 for	 the	 presence	 of	 water	 molecules	 in	 the	
complexes	[34].		
	
3.2.2.	Electronic	spectra	
	
The	electronic	spectra	of	the	complexes	were	recorded	 in	
1×10‐5	mol/L	in	DMF	in	the	range	200‐800	nm.	The	absorption	
observed	 at	 the	 wavelength	 365	 and	 430	 nm	 (Figure	 2)	 are	
assignable	 to	 the	 intramolecular	 ligand‐to‐metal	 charge	
transfer	(LMCT)	transitions	from	the	π	orbital	on	the	nitrogen	
and	 sulfur	 to	 the	 empty	d	 orbitals	 of	 the	metal.	Whereas	 the	
other	bands	in	the	higher	energy	region	(220‐263	nm)	for	the	
complexes	are	likely	to	be	due	to	intra‐ligand	π‐π*	transitions	
[24].	 The	 shoulder	 at	 about	 270‐274	 nm	 for	 complexes	
corresponds	 to	LMCT	band	of	V=O	[35].	 It	was	observed	 that	
all	bands	of	the	free	ligands	shift	to	lower	energy	in	complexes	
indicating	the	coordination	of	ligands	to	the	metal	ions.	
The	 possible	 structures	 of	 the	 synthesized	 oxovana‐
dium(V)	 complexes	 are	presumed	by	 elemental	 analysis.	 The	
complexes	 contains	 two	 chelating	 ligands	 bidentate	 and	
tridentate	with	a	ratio	of	1:2	and	1:1	 (M:L),	 respectively.	The	
complexes	 with	 bidentate	 ligands	 have	 one	 oxo‐group	
attached	to	the	vanadium	center	(Structure	1a	and	b,	Scheme	
2)	 with	 one	 NH4	 molecule	 in	 all	 complexes	 and	 two	 H2O	
crystalline	 molecules	 in	 some	 complexes.	 The	 structure	 is	
expected	 to	be	distorted	square‐pyramidal	 for	 the	complexes	
with	 the	 bidentate	 ligands.	 Similarly,	 a	 distorted	 square‐
pyramidal	 structure	 for	 complexes	with	 tridentate	 ligands	 in	
which	 the	 VO2	 in	 the	 cis‐configuration	 for	 the	 monovana‐
dium(V)	complexes,	[VO2(Lg‐h)2]	[27].	
	
3.2.3.	1H	NMR	spectra	data		
	
1H	 NMR	 spectra	 of	 ligands	 and	 metal	 complexes	 were	
recorded	 in	 DMSOd6	 using	 tetra	 methyl	 silane	 (TMS)	 as	
internal	standard.	The	1H	NMR	spectra	of	Schiff	bases	show	the	
‐SH	proton	at	δ	13.2‐13.7	ppm.	Disappearance	of	this	signal	of	
the	 ‐SH	 proton	 in	 the	 metal	 complexes	 supports	 the	
deprotonation	 of	 the	 thio‐group	 and	 this	 supported	 the	
coordination	 of	 ligands	 through	 sulphur	 atom	 to	 the	 central	
vanadium	 metal	 ion	 [25].	 The	 spectra	 of	 some	 free	 ligands	
exhibit	an	OH	(phenolic)	proton	at	δ	11.80	ppm.	The	absence	
of	 this	 signal	 in	 the	 complexes	 is	 in	 accordance	 with	
iminolization	 and	 subsequent	 replacement	 of	H	 by	 the	metal	
ion.	The	singlet	at	δ	9.13	and	8.71	ppm	in	the	spectrum	of	the	
ligands	 were	 assigned	 to	 azomethine	 proton	 (H‐C=N)	 [36].	
When	 the	metal	 is	 coordinated,	 the	 deshielding	 effect	 of	 the	
metal	atom	is	apparent	 in	some	protons,	causing	a	downfield	
shift	 of	 the	 corresponding	 1H	 NMR	 peaks.	 A	 significant	
downfield	shift	for	the	azomethine	(CH=N)	proton	signal	in	the	
complexes	 with	 respect	 to	 the	 corresponding	 free	 ligands	
confirms	the	coordination	of	the	azomethine	nitrogen	atom.	
	
3.2.4.	Thermogravimetric	analysis	
	
Thermogravimetric	 analysis	 (TGA)	data	 (Figure	3)	 shows	
that	 complexes	 undergo	 multistage	 decomposition.	 Figure	 3	
shows	 the	 TGA	 measurement	 of	 the	 complex	 NH4[VO(Ld)2].	
2H2O	which	was	performed	in	the	temperature	range	of	0‐800	
°C.	The	scanning	rate	was	10	°C/min	to	800	°C	in	the	presence	
of	 nitrogen	 gas	 flow.	 The	 thermal	 decomposition	 of	
NH4[VO(Ld)2].2H2O	 complex	 consists	 mainly	 of	 three	 stages.	
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The	first	step	complex	display	a	weight	loss	at	around	100	°C	
that	 corresponds	 to	 two	 lattice	 water	 molecules	 present	 in	
complex	 (calcd.	 4.8%,	 found	 4.87%).	 The	 second	 TG	 step	 at	
100‐350	 °C	 represents	 a	 mass	 loss	 (calcd.	 35.53%,	 found	
35.36%)	 corresponding	 to	 the	 removal	 of	 organic	 moiety	
[C14H10Cl2]	 and	 NH3	 gas.	 The	 final	 step	 corresponds	 to	
decomposition	 of	 triazole	 molecules	 at	 350‐800	 °C	 of	 the	
ligand	leading	to	the	final	residue	at	800	°C	as	metal	oxide.	The	
results	 show	 good	 agreement	 with	 the	 formulae	 suggested	
from	 the	 analytical	 data	 [37,38].	 The	 total	 decomposition	
process	can	be	represented	as:	
	
NH4[VO(Ld)2].2H2O	→	V2O5	+	Volatile	products		 	 (1)	
	
	
	
Figure	3.	Thermogravimetric	(TGA)	curve	of	NH4[VO(Ld)2].2H2O	complex.
	
3.3.	Anti‐microbial	activity	
	
The	 synthesized	 organic	 Schiff	 base	 ligands	 and	 their	
corresponding	 vanadium(V)	 complexes	 were	 assessed	 for	
microbial	 susceptibility	 against	 three	 strain	 Gram‐positive	
bacteria	 Staphylococcus	 aureus,	 Enterococcus	 faecalis,	 and	
Group	B	streptococcus	(GBS)	and	three	Gram‐negative	bacteria	
Proteus	mirabilis,	Escherichia	coli	 and	Klebsiella	pneumonia	 in	
addition,	 to	 one	 kind	 of	 pathogenic	 fungus	 Candida	 albicans.	
These	bacteria	and	fungus	types	are	selected	because	they	are	
widely	distributed	at	Albaha	region,	Kingdom	of	Saudi	Arabia,	
the	 place	 where	 this	 study	 was	 carried	 out.	 Well	 Diffusion	
method	 was	 used	 as	 testing	 method	 for	 microbial	 suscep‐
tibility	 using	 DMSO	 as	 solvent	 and	 as	 a	 control.	 After	 the	
incubation	period,	 the	microbial	susceptibility	was	monitored	
by	measuring	the	zones	(in	cm)	around	each	hole	at	which	the	
visible	growth	was	completely	inhibited.	The	results	indicated	
that	most	of	the	compounds	did	not	show	any	activity	against	
all	 types	 of	 bacteria	 except	 compound	 (NH4[VO2(Lc)2])	 have	
moderate	 activity	 against	 the	 Gram‐positive	 Group	 B	
Streptococcus	bacteria	(inhibition	zone	of	1.15	cm).	The	tested	
vanadium	 complex	 compounds	 showed	 antifungal	 suscep‐
tibility	when	used	in	the	powder	 form	against	the	pathogenic	
fungus	 C.	 albicans	 with	 highest	 sensitivity	 was	 of	 compound	
(NH4[VO2(La)2].2H2O)	with	 an	 inhibition	 zone	 =	1.65	 cm.	 The	
organic	 Schiff	 base	 ligands	 did	 not	 show	 any	 antifungal	
susceptibility	 against	 C.	 albicans	 fungus.	 In	 general	 metal	
complexes	have	 some	moderate	 antifungal	 activity	 compared	
to	 the	 free	 ligands	 and	 did	 not	 show	 sound	 antibacterial	
activity.	 The	 moderate	 antifungal	 activity	 of	 the	 complexes	
may	 be	 due	 to	 chelation	 tended	 to	 make	 the	 ligands	 more	
active	 as	 fungicides	 due	 to	 factors	 like	 solubility	 and	
permeability.	These	 factors	are	 influenced	by	 the	presence	of	
vanadium	ion	that	might	be	the	possible	reason	for	increasing	
activity.	These	results	are	in	accordance	with	reports	of	earlier	
workers	[37].	
	
	
4.	Conclusion	
	
Two	series	of	bidentate	and	tridentate	Schiff’s	base	ligands	
containing	 triazole	 moiety	 were	 synthesized	 and	 combined	
with	 ammonium	 metavanadate	 in	 2:1	 and	 1:1	 (L:M)	 molar	
ratio	 in	 case	 of	 bidentate	 ligands	 and	 tridentate	 ligands,	
respectively.	Two	types	of	monomeric	vanadium(V)	complexes	
(oxo‐	and	dioxo‐)	were	formed.	The	complexes	with	bidentate	
ligands	 were	 having	 one	 oxo	 group	 (V=O),	 while	 complexes	
with	 tridentate	 ligands	 were	 having	 two	 oxo‐groups	 (V=O).	
The	 possible	 structures	 of	 the	 synthesized	 oxo/dioxvana‐
dium(V)	 complexes	 are	 presumed	 by	 elemental	 analysis,	 IR,	
UV‐visible,	 NMR,	 MS	 and	 TGA.	 The	 structure	 is	 expected	 to	
have	 a	 distorted	 square	 pyramidal	 geometry	 for	 all	 the	
complexes.	The	compounds	were	tested	for	their	antibacterial	
and	 antifungal	 activity.	 Observations	 indicated	 that	 the	
synthesized	 vanadium	 complexes	 were	 moderately	 active	
against	 C.	 albicans	 fungus	 where,	 the	 metal	 complexes	 are	
more	 active	 compared	 to	 the	 free	 ligands.	 The	 ligands	 and	
their	 vanadium	 complexes	 did	 not	 show	 any	 antibacterial	
activity.		
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